GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93019C00007MOLECULAR EXPRESS, INC

Overview

Award facts

Net obligations
$599.98K
$599,983of $599.98K potential value
Outlays (paid to date)
$50K
$50K paid of $599.98K obligated$49,999
Period of performance
May 31, 2019 to May 30, 2021
Ended
Modifications
0
Latest action May 30, 2019
Contract type
Definitive contract
PIID 75N93019C00007

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP AN EFFECTIVE HIV VACCINE BY EXPLORING CO-DELIVERY FORMULATIONS OF HIVANTIGENS AND ADJUVANTS.

Dates and value

Award date
Signed on May 30, 2019
Potential end of performance
May 29, 2021
Current value
$599,983Base and exercised options
Potential value (if all options are exercised)
$599,983

Obligations by fiscal year of action

  • FY2019: $599,983

Total across 1 fiscal year: $599,983

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 30, 2019. View on USAspending · Recipient on SAM.gov

Recipient

LocationRANCHO DOMINGUEZ, CA
UEIR1JMHFESEKD5
CAGE code337D8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMOLECULAR EXPRESS INC

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Compton, Los Angeles County, California 90220-5610
Congressional district (place of performance)
CA-44As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
SBIRPHS20191(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Evaluation of vesivax adjuvant formulations for hiv vaccines
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
May 30, 2019Base obligation at award: $599,983
Latest action
May 30, 2019 — Base awardModification 0; obligation change +$599,983
Actions by type
  • Base award1
1 actions recorded, May 30, 2019 to May 30, 2019; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$599,983
Latest action: change in base and all options
$599,983

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
1

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2019/2019-0885-000
Object classes
  • 25.5: Research and development contracts